Biotech

Atossa Genetics Subsidiary The NRLBH Now Provides Enhanced Pharmacogenetic Test Based on Luminex xTAG Platform

SEATTLE, WA: ...

Dynavax Announces Proposed Public Offering of Common Stock

BERKELEY, CA: ...

Cleveland BioLabs to Report Second Quarter 2015 Financial Results on August 3

BUFFALO, NY: ...

Highly-Touted Gastrointestinal Surgeon and Metabolism Researcher Dr. Oliver F. Bathe Named Adviser to M Pharmaceutical, Inc.

VANCOUVER, BRITISH COLUMBIA: Leader of the provincial gastrointestinal tumour team at the Tom Baker Cancer Centre at the University of Calgary joins an impressive Advisory Board for Canadian biomedical technology company focused ...

M Pharmaceutical Inc. Rebrands Itself to Better Reflect Growing Family of Biomedical Technologies

VANCOUVER, BRITISH COLUMBIA: New Corporate Identity Will Enhance Understanding of Biomedical Technologies Designed to Improve the Health of Those Affected by Obesity and Diabetes ...

Clinical Ink Announces CentrosHealth Platform Captures Medical Device Data

WINSTON-SALEM, NC and PHILADELPHIA, PA: Clinical Ink Collaborates With Novartis, PPD and Qualcomm Life to Collect Medical Device Data via Smartphone App ...

Damien Reynolds Appointed Chief Capital Markets Officer

VANCOUVER, BRITISH COLUMBIA: ...

EGRIFTA(TM) (Tesamorelin for Injection) Approved in Mexico

MONTREAL, CANADA: ...

Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review Publication Initiatives

MELBOURNE, AUSTRALIA: ...

Corbus Pharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of Resunab(TM) for the Treatment of Dermatomyositis

NORWOOD, MA: ...